-
Case Report
-
J Mult Scler Neuroimmunol. 2021;12(2):39-42. Published online December 1, 2021.
- 리툭시맙에 치료효과를 보인 만성염증탈수초다발신경병
-
김다영, 최교민, 오지영
-
건국대학교병원 신경과
-
- Successful Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy with Rituximab
-
Dayoung Kim, Kyomin Choi, Jeeyoung Oh
-
Department of Neurology, Konkuk University Medical Center, Seoul, Korea
-
- Abstract
- "Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a heterogeneous autoimmune disease characterized by a relapsing and remitting or progressive pattern. Corticosteroid, intravenous immunoglobulin or plasma exchange are usually used as treatment options. However, approximately one-third of patients with CIDP have an inadequate response to standard treatments. Rituximab, a monoclonal antibody against CD20, has been used with good results in some patients with refractory CIDP. We report a patient with refractory CIDP in whom remission has been successfully maintained after treatment with rituximab. Journal of Multiple Sclerosis and Neuroimmunology 12(2):39-42, 2021"
Keywords :Polyradiculoneuropathy, Chronic inflammatory demyelinatin; Rituximab
